Array BioPharma News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Trading-Depot

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

05.03.18	Array BioPharma To Present At The Cowen 38th Annual Healthcare Conference (PR Newswire)
07.02.18	Array BioPharma To Present At The LEERINK Partners 7th Annual Global Healthcare Conference (PR Newswire)
07.02.18	ARRY's COLUMBUS Turns Heads, ZFGN On Course, MNOV UP 66% YTD (RTTNews)
06.02.18	Array BioPharma Announces Results Of Phase 3 COLUMBUS Trial (RTTNews)
06.02.18	EARNINGS SUMMARY: Details of Array BioPharma Inc. Q2 Earnings Report (RTTNews)
06.02.18	Array BioPharma Reports Financial Results For The Second Quarter of Fiscal 2018 (PR Newswire)
06.02.18	Encorafenib and Binimetinib Combination Treatment Demonstrates 33.6 Month Median Overall Survival (OS) in Patients with BRAF-Mutant Melanoma in Phase 3 COLUMBUS Trial (PR Newswire)
30.01.18	Array BioPharma To Report Financial Results For The Second Quarter Of Fiscal 2018 On February 6, 2018 (PR Newswire)
23.01.18	ARRY Shines A BEACON, So Long To JUNO And BIVV, Exciting Time Ahead For GEMP (RTTNews)
20.01.18	Combination of Encorafenib, Binimetinib and Cetuximab Demonstrated an 8 Month Median Progression-Free Survival in BRAF-Mutant Colorectal Cancer in Updated Safety Lead-In Results from BEACON Phase 3... (PR Newswire)
16.01.18	Array BioPharma to Present Updated Phase 3 BEACON CRC Safety Lead-In Results of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant Colorectal Cancer at the 2018... (PR Newswire)
23.12.17	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Array Biopharma Inc. of Class Action Lawsuit and Upcoming Deadline - ARRY (PR Newswire)
19.12.17	Array BioPharma Enters Into Clinical Trial Collaboration Agreement With Pfizer (RTTNews)
19.12.17	Array BioPharma Announces Strategic Collaboration with Pfizer (PR Newswire)
01.12.17	ARRAY BIOPHARMA LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Array Biopharma, Inc. To Contact The Firm (PR Newswire)
27.11.17	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Array Biopharma, Inc. (ARRY) & Lead Plaintiff Deadline: January 22, 2018 (PR Newswire)
22.11.17	Array BioPharma To Present At The 2017 Piper Jaffray Healthcare Conference (PR Newswire)
22.11.17	Array BioPharma To Present At The 2017 Piper Jaffray Healthcare Conference (PR Newswire)
21.11.17	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Array Biopharma, Inc. - ARRY (PR Newswire)
21.11.17	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Array Biopharma, Inc. (ARRY) (PR Newswire)
16.11.17	Array BioPharma Announces Private Exchange of $107 Million of its 3.00% Convertible Senior Notes due 2020 for its 2.625% Convertible Senior Notes due 2024 and Shares of its Common Stock (PR Newswire)
13.11.17	Array BioPharma Reports Initial Results From Novel Immunotherapy Combination At The Society For Immunotherapy Of Cancer (SITC) 32nd Annual Meeting (PR Newswire)
08.11.17	Array BioPharma To Present At The 2017 Stifel Healthcare Conference (PR Newswire)
31.10.17	EARNINGS SUMMARY: Details of Array BioPharma Inc. Q1 Earnings Report (RTTNews)
31.10.17	Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2018 (PR Newswire)
24.10.17	Array Biopharma To Report Financial Results For The First Quarter Of Fiscal 2018 On October 31, 2017 (PR Newswire)
29.09.17	Electric Cloud Participates in 10 DevOps Events in October to Help Enterprises Scale and Streamline Software Delivery (PR Newswire)
19.09.17	Array BioPharma To Present At The 2017 Cantor Fitzgerald Global Healthcare Conference (PR Newswire)
19.09.17	Array BioPharma Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares (PR Newswire)
15.09.17	Array BioPharma Announces Pricing of Public Offering of Common Stock (PR Newswire)
14.09.17	Array BioPharma Shows Significant Rebound After Initial Sell-Off (RTTNews)
13.09.17	Array BioPharma Announces Proposed Public Offering of Common Stock (PR Newswire)
12.09.17	Rock Legend And Media Mogul Gene Simmons To Celebrate 50 Years In Rock With "THE VAULT EXPERIENCE" (PR Newswire)
12.09.17	Array BioPharma Announces FDA Acceptance For Review Of Binimetinib And Encorafenib New Drug Applications For Patients With Advanced BRAF-mutant Melanoma (PR Newswire)
11.09.17	Shopoff Realty Investments Acquires 577 Acres of Land in Southern California's Inland Empire (PR Newswire)
11.09.17	New Hope For AZN's Old Drug, More About BMY's Opdivo, IMDZ On Watch (RTTNews)
09.09.17	Phase 3 COLUMBUS Part 2 Results in BRAF-Mutant Melanoma Presented at European Society for Medical Oncology Congress (PR Newswire)
08.09.17	Phase 3 BEACON CRC Safety Lead-In Results in BRAF-Mutant Colorectal Cancer Presented at European Society for Medical Oncology Congress (PR Newswire)
07.09.17	Prospect General Launches Admitted Residential Flood Program in Utah (PR Newswire)
30.08.17	Array Biopharma To Present BEACON CRC Safety Lead-in And COLUMBUS Part 2 Results At European Society For Medical Oncology Congress (ESMO) (PR Newswire)
28.08.17	Array BioPharma To Present At The 2017 Wells Fargo Healthcare Conference (PR Newswire)
14.08.17	Array BioPharma Appoints Curtis Oltmans As General Counsel (PR Newswire)
09.08.17	EARNINGS SUMMARY: Details of Array BioPharma Inc. Q4 Earnings Report (RTTNews)
09.08.17	Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2017 (PR Newswire)
03.08.17	Array BioPharma To Report Financial Results For The Fourth Quarter And Full Year Of Fiscal 2017 On August 9, 2017 (PR Newswire)
27.07.17	Technical Reports on Biotech Equities -- Opko Health, Array BioPharma, Immunomedics, and TG Therapeutics (PR Newswire)
18.07.17	Amgen And Array BioPharma Announce Preclinical License And Collaboration Agreement In Inflammation (PR Newswire)
06.07.17	Pharma Stocks Taking Measures to Boost Growth (PR Newswire)
06.07.17	Pharma Stocks Taking Measures to Boost Growth (PR Newswire)
06.07.17	ARRY Working Its Way, Be All Ears For Auris, BGNE Inks Deal With CELG (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

16:16		EVOTEC-Aktie rutscht ab: Operatives Ergebnis mehr als halbiert
10:02		TecDAX-Papier EVOTEC SE-Aktie: So viel Verlust hätte ein Investment in EVOTEC SE von vor 3 Jahren bedeutet
30.04.25		EVOTEC SE-Aktie: Das sind die Analysten-Einstufungen des vergangenen Monats
29.04.25		TecDAX-Wert EVOTEC SE-Aktie: So viel Verlust hätte eine Investition in EVOTEC SE von vor einem Jahr bedeutet
24.04.25		EVOTEC-Aktie steigt: Millionen-Zahlung von Bristol Myers Squibb
22.04.25		TecDAX-Wert EVOTEC SE-Aktie: So viel hätten Anleger mit einem Investment in EVOTEC SE von vor 10 Jahren verdient
17.04.25		EVOTEC-Aktie zieht kräftig an: EVOTEC erfüllt Jahresprognose 2024 trotz rückläufigem Ergebnis
15.04.25		TecDAX-Papier EVOTEC SE-Aktie: So viel hätten Anleger mit einem Investment in EVOTEC SE von vor 5 Jahren verloren

16:16

EVOTEC-Aktie rutscht ab: Operatives Ergebnis mehr als halbiert

10:02

TecDAX-Papier EVOTEC SE-Aktie: So viel Verlust hätte ein Investment in EVOTEC SE von vor 3 Jahren bedeutet

30.04.25

EVOTEC SE-Aktie: Das sind die Analysten-Einstufungen des vergangenen Monats

29.04.25

TecDAX-Wert EVOTEC SE-Aktie: So viel Verlust hätte eine Investition in EVOTEC SE von vor einem Jahr bedeutet

24.04.25

EVOTEC-Aktie steigt: Millionen-Zahlung von Bristol Myers Squibb

22.04.25

TecDAX-Wert EVOTEC SE-Aktie: So viel hätten Anleger mit einem Investment in EVOTEC SE von vor 10 Jahren verdient

17.04.25

EVOTEC-Aktie zieht kräftig an: EVOTEC erfüllt Jahresprognose 2024 trotz rückläufigem Ergebnis

15.04.25

TecDAX-Papier EVOTEC SE-Aktie: So viel hätten Anleger mit einem Investment in EVOTEC SE von vor 5 Jahren verloren

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nestle	88.22	1.01 %	K V
Swisscom	550.50	0.92 %	K V
Swiss Re	152.20	0.76 %	K V
Zurich Insur Gr	594.80	0.57 %	K V
Swiss Life Hldg	845.40	0.45 %	K V
Lonza Grp	593.20	-0.80 %	K V
Logitech Intl	63.48	-1.28 %	K V
Alcon	79.62	-1.31 %	K V
ABB	44.66	-1.61 %	K V
Kuehne+Nagel Int	187.00	-2.58 %	K V

Array BioPharma Aktie VALOR 1158161 / ISIN US04269X1054

Nachrichten zu Array BioPharma Inc.

Aktien Top/Flop

Array BioPharma Peer Group Nachrichten

Meistgelesene Nachrichten